Sanaria is a biotechnology company dedicated to the production of a vaccine protective against malaria caused by the pathogen Plasmodium falciparum. Sanaria’s vaccine is based on an approach to immunization that has already proven highly protective in humans.
View Top Employees from Sanaria Inc.Website | http://www.sanaria.com |
Revenue | $24 million |
Funding | $2.1 million |
Employees | 80 (80 on RocketReach) |
Founded | 2003 |
Address | 9800 Medical Center Drive SuiteA209, Rockville, Maryland 20850, US |
Phone | (301) 770-3222 |
Fax | (301) 770-5554 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Category | Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Vaccine Development, Health Care, Life Science |
Web Rank | 8 Million |
Keywords | sanaria, malaria vaccine biotech |
Competitors | AlphaVax, Bavarian Nordic, Biological E limited, SINOVAC BIOTECH LTD., Vaxxinova |
SIC | 28, 283 |
NAICS | 325414, 3254, 32541, 32, 325 |
Looking for a particular Sanaria Inc. employee's phone or email?
The Sanaria Inc. annual revenue was $24 million in 2023.
Thomas Richie is the Chief Medical Officer of Sanaria Inc..
80 people are employed at Sanaria Inc..
Sanaria Inc. is based in Rockville, Maryland.
The NAICS codes for Sanaria Inc. are [325414, 3254, 32541, 32, 325].
The SIC codes for Sanaria Inc. are [28, 283].